News Related to Cardiometabolic Disease

Related coverage linked through entity extraction aliases.

Cardiovascular Biologics and Cell Therapy Markets Project Strong Growth Through 2033

Mar 05, 2026

The cardiovascular biologics market is projected to reach $4.23 billion by 2033, while the cell therapy market is expected to reach $5.38 billion by 2032, driven by RNA-based therapies and regulatory approvals.

Merck and Mayo Clinic Launch AI-Driven Drug Discovery Partnership

Feb 18, 2026

Merck partners with Mayo Clinic in a strategic research and development agreement to apply artificial intelligence and advanced analytics to drug discovery, integrating Mayo Clinic's clinical and genomic datasets with Merck's AI-enabled technologies.